Edition:
United Kingdom

OpGen Inc (OPGN.OQ)

OPGN.OQ on NASDAQ Stock Exchange Capital Market

1.78USD
17 Aug 2018
Change (% chg)

$-0.02 (-1.11%)
Prev Close
$1.80
Open
$1.80
Day's High
$1.80
Day's Low
$1.77
Volume
10,943
Avg. Vol
62,539
52-wk High
$10.25
52-wk Low
$1.62

Chart for

About

OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening... (more)

Overall

Beta: --
Market Cap(Mil.): $15.20
Shares Outstanding(Mil.): 51.56
Dividend: --
Yield (%): --

Financials

  OPGN.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.78 -- --
ROI: -409.94 1.78 14.61
ROE: -649.89 3.28 16.33

BRIEF-Opgen Reports Q1 Loss Per Share Of $0.75

* OPGEN REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

08 May 2018

BRIEF-Opgen Reports Q4 Loss Per Share $1.33

* OPGEN REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

15 Mar 2018

BRIEF-Opgen Says Collaborating With Beth Israel Deaconess Medical Center In Boston

* OPGEN ANNOUNCES COLLABORATOR IN VERIFICATION STUDY FOR ACUITAS® TEST

13 Mar 2018

Earnings vs. Estimates